Baker Avenue Asset Management, LP Biogen Inc. Transaction History

Baker Avenue Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $31,662 - $35,736	125 Added 215.52%	183 $47,000
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $275 - $318	-1 Reduced 1.69%	58 $16,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $256 - $292	1 Added 1.72%	59 $16,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $14,641 - $17,789	58 New	58 $16,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.